REPLIGEN CORP

RGEN · XNAS

CIK 730272fmd_0VBS3PAVQ4VE689FHEH3FJKCJ4Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Apr 01, 2009 to Sep 30, 2026, 68 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.